These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19440974)

  • 1. Identification of three distinguishable phenotypes in golden retriever muscular dystrophy.
    Ambrósio CE; Fadel L; Gaiad TP; Martins DS; Araújo KP; Zucconi E; Brolio MP; Giglio RF; Morini AC; Jazedje T; Froes TR; Feitosa ML; Valadares MC; Beltrão-Braga PC; Meirelles FV; Miglino MA
    Genet Mol Res; 2009 Apr; 8(2):389-96. PubMed ID: 19440974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscular dystrophy in a family of Labrador Retrievers with no muscle dystrophin and a mild phenotype.
    Vieira NM; Guo LT; Estrela E; Kunkel LM; Zatz M; Shelton GD
    Neuromuscul Disord; 2015 May; 25(5):363-70. PubMed ID: 25813339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major clinical and histopathological characteristics of canine X-linked muscular dystrophy in Japan, CXMDJ.
    Shimatsu Y; Yoshimura M; Yuasa K; Urasawa N; Tomohiro M; Nakura M; Tanigawa M; Nakamura A; Takeda S
    Acta Myol; 2005 Oct; 24(2):145-54. PubMed ID: 16550932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the six-minute walk test to characterize golden retriever muscular dystrophy.
    Acosta AR; Van Wie E; Stoughton WB; Bettis AK; Barnett HH; LaBrie NR; Balog-Alvarez CJ; Nghiem PP; Cummings KJ; Kornegay JN
    Neuromuscul Disord; 2016 Dec; 26(12):865-872. PubMed ID: 27818009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association study to identify potential genetic modifiers in a canine model for Duchenne muscular dystrophy.
    Brinkmeyer-Langford C; Balog-Alvarez C; Cai JJ; Davis BW; Kornegay JN
    BMC Genomics; 2016 Aug; 17(1):665. PubMed ID: 27549615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cranial sartorius muscle undergoes true hypertrophy in dogs with golden retriever muscular dystrophy.
    Kornegay JN; Cundiff DD; Bogan DJ; Bogan JR; Okamura CS
    Neuromuscul Disord; 2003 Aug; 13(6):493-500. PubMed ID: 12899877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired autophagy correlates with golden retriever muscular dystrophy phenotype.
    Stoughton WB; Li J; Balog-Alvarez C; Kornegay JN
    Muscle Nerve; 2018 Sep; 58(3):418-426. PubMed ID: 29513363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ringo: discordance between the molecular and clinical manifestation in a golden retriever muscular dystrophy dog.
    Zucconi E; Valadares MC; Vieira NM; Bueno CR; Secco M; Jazedje T; da Silva HC; Vainzof M; Zatz M
    Neuromuscul Disord; 2010 Jan; 20(1):64-70. PubMed ID: 19944604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20.
    Mata López S; Hammond JJ; Rigsby MB; Balog-Alvarez CJ; Kornegay JN; Nghiem PP
    Skelet Muscle; 2018 May; 8(1):16. PubMed ID: 29843823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive Immune Response Impairs the Efficacy of Autologous Transplantation of Engineered Stem Cells in Dystrophic Dogs.
    Sitzia C; Farini A; Jardim L; Razini P; Belicchi M; Cassinelli L; Villa C; Erratico S; Parolini D; Bella P; da Silva Bizario JC; Garcia L; Dias-Baruffi M; Meregalli M; Torrente Y
    Mol Ther; 2016 Nov; 24(11):1949-1964. PubMed ID: 27506452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor physical therapy affects muscle collagen type I and decreases gait speed in dystrophin-deficient dogs.
    Gaiad TP; Araujo KP; Serrão JC; Miglino MA; Ambrósio CE
    PLoS One; 2014; 9(4):e93500. PubMed ID: 24713872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical therapy assessment tools to evaluate disease progression and phenotype variability in Golden Retriever muscular dystrophy.
    Gaiad TP; Silva MB; Silva GC; Caromano FA; Miglino MA; Ambrósio CE
    Res Vet Sci; 2011 Oct; 91(2):188-93. PubMed ID: 21315399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscular dystrophy in dogs: does the crossing of breeds influence disease phenotype?
    Miyazato LG; Moraes JR; Beretta DC; Kornegay JN
    Vet Pathol; 2011 May; 48(3):655-62. PubMed ID: 21233328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation.
    Robriquet F; Babarit C; Larcher T; Dubreil L; Ledevin M; Goubin H; Rouger K; Guével L
    BMC Musculoskelet Disord; 2016 May; 17():209. PubMed ID: 27170302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of dystrophic muscle in golden retriever muscular dystrophy dogs by nuclear magnetic resonance imaging.
    Thibaud JL; Monnet A; Bertoldi D; Barthélémy I; Blot S; Carlier PG
    Neuromuscul Disord; 2007 Jul; 17(7):575-84. PubMed ID: 17537632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Golden retriever muscular dystrophy (GRMD): Developing and maintaining a colony and physiological functional measurements.
    Kornegay JN; Bogan JR; Bogan DJ; Childers MK; Grange RW
    Methods Mol Biol; 2011; 709():105-23. PubMed ID: 21194024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle percentage index as a marker of disease severity in golden retriever muscular dystrophy.
    Eresen A; Hafsa NE; Alic L; Birch SM; Griffin JF; Kornegay JN; Ji JX
    Muscle Nerve; 2019 Nov; 60(5):621-628. PubMed ID: 31397906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies.
    Banks GB; Chamberlain JS
    Curr Top Dev Biol; 2008; 84():431-53. PubMed ID: 19186250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum profiling identifies novel muscle miRNA and cardiomyopathy-related miRNA biomarkers in Golden Retriever muscular dystrophy dogs and Duchenne muscular dystrophy patients.
    Jeanson-Leh L; Lameth J; Krimi S; Buisset J; Amor F; Le Guiner C; Barthélémy I; Servais L; Blot S; Voit T; Israeli D
    Am J Pathol; 2014 Nov; 184(11):2885-98. PubMed ID: 25194663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.